China Medical University Hospital
Title: The beneficial effects of probiotics in peritoneal dialysis patients.
I-Kuan Wang1,2, Ya-Fei Yang2, I-Wen Ting2, Chung-Chih Lin2, Yao-Lung Liu2, Che-Yi Chou2, Jiung-Hsiun
Liu2, Shih-Yi Lin2, Hung-Chih Lin3, and Chiu-Ching Huang2
1Graduate institute of clinical medical science, College of medicine, China medical University, 2Division of
nephrology, China medical university hospital, 3Deparment of pediatrics, China medical university hospital.
Background
Inflammatory markers such as interleukin 6 (IL-6) and tumor necrosis factor-α (TNF-α) are elevated in dialysis patients and can predict cardiovascular events and all-cause mortality. Endotoxin is an important source and another marker of inflammation in patients with chronic kidney disease. The aim of this study was to evaluate the impact of oral probiotics on serum levels of cytokines and endotoxemia in peritoneal dialysis (PD) patients.
Materials and methods
From March 2011 to June 2012, a randomized, double-blind, placebo-controlled trial was conducted in PD patients at China Medical University Hospital. After obtaining informed consent, the intervention group received probiotics containing 109 colony-forming units (CFU) B. bifidum A218, 109 CFU B. catenulatum
A302, 109 CFU B. longum A101, and 109 CFU L. plantarum A87 daily for six months, while the placebo group
received similar capsules containing maltodextrin for the same duration. Levels of serum TNF-α, INF-γ, IL-5, IL-6, IL-10, IL-17, and endotoxin were measured before and six months after intervention.
Results
Thirty-nine patients completed the study (21 in the probiotics group and 18 in the placebo group). In patients receiving probiotics, levels of serum TNF-α, IL-5, IL-6, and endotoxin significantly decreased after six months of treatment, while levels of serum IL-10 significantly increased. In contrast, there were no significant changes in levels of serum cytokines and endotoxin in the placebo group after six months.
Conclusions
Probiotics could significantly reduce the serum levels of endotoxin, pro-inflammatory cytokines (TNF-α and IL-6), IL-5, and increase the serum levels of anti-inflammatory cytokine (IL-10) in PD patients.
Patients included in this study.
The distribution of serum levels of cytokines and endotoxin in
peritoneal dialysis patients before and after treatment.